{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:34Z","timestamp":1786119394119,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/mcg.0b013e3181a745e7","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T08:30:15Z","timestamp":1261038615000},"page":"e20-e22","source":"Crossref","is-referenced-by-count":63,"title":["Adalimumab-induced Autoimmune Hepatitis"],"prefix":"10.1097","volume":"44","author":[{"given":"Tomer","family":"Adar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Pappo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Scheiman-Elazary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Shibolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-4-20210305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncprheum0825","article-title":"Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases","volume":"4","author":"Langford","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R3-4-20210305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.gtc.2006.09.008","article-title":"Safety of infliximab and other biologic agents in the inflammatory bowel diseases","volume":"35","author":"Reddy","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"R4-4-20210305","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(02)07718-8","article-title":"Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis","volume":"359","author":"Day","year":"2002","journal-title":"Lancet"},{"key":"R5-4-20210305","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","author":"Tobon","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R6-4-20210305","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","article-title":"Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis","volume":"187","author":"Ozorio","year":"2007","journal-title":"Med J Aust"},{"key":"R7-4-20210305","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R8-4-20210305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"R9-4-20210305","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1572-0241.2001.03707.x","article-title":"Understanding the pathogenesis of autoimmune hepatitis","volume":"96","author":"Czaja","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R10-4-20210305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1089-3261(05)70097-0","article-title":"Drug-induced liver disease","volume":"4","author":"Zimmerman","year":"2000","journal-title":"Clin Liver Dis"},{"key":"R11-4-20210305","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"key":"R12-4-20210305","first-page":"1624","article-title":"Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease","volume":"30","author":"Michel","year":"2003","journal-title":"J Rheumatol"},{"key":"R14-4-20210305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","article-title":"Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha","volume":"64","author":"Eriksson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R15-4-20210305","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","author":"Germano","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R16-4-20210305","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ibd.20293","article-title":"Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis","volume":"14","author":"Marques","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R17-4-20210305","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3","article-title":"Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al","volume":"44","author":"Saleem","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R18-4-20210305","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/RHU.0b013e318188b1df","article-title":"Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept","volume":"14","author":"Fathalla","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"R19-4-20210305","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10067-008-0885-1","article-title":"A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis","volume":"27","author":"Harada","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R20-4-20210305","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s10067-008-1000-3","article-title":"Etanercept tolerance in a patient with previous infliximab-induced hepatitis","volume":"27","author":"Becker","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R21-4-20210305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09546630500424722","article-title":"Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis","volume":"16","author":"Goldenberg","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"R22-4-20210305","first-page":"440","article-title":"Elevated liver enzymes in rheumatoid arthritis: differential diagnostic considerations based on a case report","volume":"67","author":"Hartmann","year":"2008","journal-title":"Z Rheumatol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-201001000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:06Z","timestamp":1786039746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-201001000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3181a745e7","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}